In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Pseudomonas aeruginosa.
作者信息
Zhu Ying, Findlay Jacqueline, Bouvier Maxime, Yang Qiwen, Xu Yingchun, Nordmann Patrice
机构信息
Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, Fribourg CH-1700, Switzerland.
出版信息
J Antimicrob Chemother. 2025 Feb 3;80(2):593-595. doi: 10.1093/jac/dkae445.
Abstract
摘要
相似文献
1
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Pseudomonas aeruginosa.针对产碳青霉烯酶铜绿假单胞菌的双碳青霉烯类联合用药的体外评估
J Antimicrob Chemother. 2025 Feb 3;80(2):593-595. doi: 10.1093/jac/dkae445.
2
Assessment of in vitro antimicrobial activities of ceftolozane/tazobactam and ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates.头孢洛扎/他唑巴坦和头孢他啶/阿维巴坦对耐碳青霉烯类铜绿假单胞菌临床分离株的体外抗菌活性评估。
BMC Infect Dis. 2025 Apr 28;25(1):622. doi: 10.1186/s12879-025-10891-w.
3
Carbapenem Combinations for Infections Caused by Carbapenemase-Producing : Experimental In Vitro and In Vivo Analysis.用于产碳青霉烯酶菌感染的碳青霉烯类联合用药：体外和体内实验分析
Antibiotics (Basel). 2022 Sep 7;11(9):1212. doi: 10.3390/antibiotics11091212.
4
Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.新型β-内酰胺/β-内酰胺酶抑制剂联合制剂对产丝氨酸碳青霉烯酶的碳青霉烯类耐药铜绿假单胞菌的活性。
J Antimicrob Chemother. 2023 Dec 1;78(12):2795-2800. doi: 10.1093/jac/dkad225.
5
Activity of Cefepime-Taniborbactam against Carbapenemase-Producing and Pseudomonas aeruginosa Isolates Recovered in Spain.头孢吡肟-他唑巴坦对在西班牙分离的产碳青霉烯酶和铜绿假单胞菌的活性。
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0216121. doi: 10.1128/aac.02161-21. Epub 2022 Jan 10.
6
Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii.多中心评价改良碳青霉烯酶灭活法和 Carba NP 检测产碳青霉烯酶铜绿假单胞菌和鲍曼不动杆菌。
J Clin Microbiol. 2017 Dec 26;56(1). doi: 10.1128/JCM.01369-17. Print 2018 Jan.
7
Carbapenem inactivation: a very affordable and highly specific method for phenotypic detection of carbapenemase-producing Pseudomonas aeruginosa isolates compared with other methods.碳青霉烯灭活：与其他方法相比，一种用于产碳青霉烯酶铜绿假单胞菌分离株表型检测的经济高效且高度特异的方法。
J Chemother. 2017 Jun;29(3):144-149. doi: 10.1080/1120009X.2016.1199506. Epub 2016 Jul 22.
8
Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing .用于检测产金属β-内酰胺酶的乙二胺四乙酸（EDTA）修饰碳青霉烯灭活方法的评估
J Clin Microbiol. 2020 May 26;58(6). doi: 10.1128/JCM.02015-19.
9
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa.ERACE-PA 全球监测计划：头孢他啶/他唑巴坦和头孢他啶/阿维巴坦对全球碳青霉烯类耐药铜绿假单胞菌的体外活性。
Eur J Clin Microbiol Infect Dis. 2021 Dec;40(12):2533-2541. doi: 10.1007/s10096-021-04308-0. Epub 2021 Jul 22.
10
Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.头孢他洛滨-他唑巴坦对产碳青霉烯酶非产碳青霉烯酶耐药铜绿假单胞菌的活性及相关耐药机制。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01970-17. Print 2018 Jan.
本文引用的文献
1
Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa.染色体编码耐药机制和可转移β-内酰胺酶对头孢地尔的活性及新型β-内酰胺/β-内酰胺酶抑制剂组合对铜绿假单胞菌的影响。
J Antimicrob Chemother. 2024 Oct 1;79(10):2591-2597. doi: 10.1093/jac/dkae263.
2
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.碳青霉烯类耐药铜绿假单胞菌和相关碳青霉烯酶（POP）的全球流行病学和临床结局：一项前瞻性队列研究。
Lancet Microbe. 2023 Mar;4(3):e159-e170. doi: 10.1016/S2666-5247(22)00329-9. Epub 2023 Feb 9.
3
The Intriguing Carbapenemases of : Current Status, Genetic Profile, and Global Epidemiology.碳青霉烯酶的研究进展：现状、基因谱和全球流行病学。
Yale J Biol Med. 2022 Dec 22;95(4):507-515. eCollection 2022 Dec.
4
Carbapenem-Only Combination Therapy against Multi-Drug Resistant : Assessment of In Vitro and In Vivo Efficacy and Mode of Action.仅用碳青霉烯类联合疗法治疗多重耐药菌：体外和体内疗效及作用方式评估
Antibiotics (Basel). 2022 Oct 25;11(11):1467. doi: 10.3390/antibiotics11111467.
5
Carbapenemase-producing -an emerging challenge.产碳青霉烯酶 - 新出现的挑战。
Emerg Microbes Infect. 2022 Dec;11(1):811-814. doi: 10.1080/22221751.2022.2048972.
6
In-vitro evaluation of a dual carbapenem combination against carbapenemase-producing Acinetobacter baumannii.针对产碳青霉烯酶鲍曼不动杆菌的双碳青霉烯类联合用药的体外评估
J Infect. 2020 Jan;80(1):121-142. doi: 10.1016/j.jinf.2019.10.003. Epub 2019 Oct 11.
7
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae.针对产碳青霉烯酶肠杆菌科细菌的双碳青霉烯类联合用药的体外评估
J Antimicrob Chemother. 2016 Jan;71(1):156-61. doi: 10.1093/jac/dkv294. Epub 2015 Sep 27.
8
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections.双碳青霉烯类方案治疗泛耐药肺炎克雷伯菌血流感染的协同活性及有效性
J Antimicrob Chemother. 2014 Jun;69(6):1718-20. doi: 10.1093/jac/dku027. Epub 2014 Feb 11.
9
Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae.产碳青霉烯酶肺炎克雷伯菌的双重碳青霉烯类治疗。
Antimicrob Agents Chemother. 2011 Jun;55(6):3002-4. doi: 10.1128/AAC.01420-10. Epub 2011 Mar 21.
Zotero 插件